Foundation Fighting Blindness

Atsena’s LCA1 Gene Therapy Licensed by Nippon Shinyaku for Markets in US and Japan


Episode Artwork
1.0x
0% played 00:00 00:00
Nov 12 2024 3 mins   4
Other Episodes
The companies are planning a Phase 3 clinical trial for the promising gene therapy.
Download episode Share
Copy URL



Listen on Podcast Addict
Subscribe on Podcast Addict